GLP-1 receptor drugs for Type 2 Diabetes
34 tracked GLP-1 receptor drugs in the Type 2 Diabetes race. The class explanation lives on the GLP-1 receptor page; the full indication pipeline across every mechanism is on the Type 2 Diabetes page.
5 approved / phase 421 Phase 37 Phase 21 Phase 1
Head-to-head evidence: Albenatide vs ASC30 · ASC30 vs Berobenatide · ASC30 vs Efmedaglutide alfa · ASC30 vs HDG1901 · ASC30 vs IcoSema · ASC30 vs Liraglutide (Victoza)